Privatization and Oligopolies of the Renal Replacement Therapy Sector on Contemporary Capitalism: A Systematic Review and the Brazilian Scenario

References

• Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ. 2018;96(6):414–422D. doi:10.2471/BLT.17.206441
   PubMed Web of Science ®Google Scholar
• Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–1982. doi:10.1016/S0140-6736(14)61601-9
   PubMed Web of Science ®Google Scholar
• Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–830. doi:10.7326/0003-4819-158-11-201306040-00007
   PubMed Web of Science ®Google Scholar
• Tonelli M, Wiebe N, Knoll G, et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011;11(10):2093–2109. doi:10.1111/j.1600-6143.2011.03686.x
   PubMed Web of Science ®Google Scholar
• Thurlow JS, Joshi M, Yan G, et al. Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol. 2021;52(2):98–107. doi:10.1159/000514550
   PubMed Web of Science ®Google Scholar
• Sloan CE, Hoffman A, Maciejewski ML, Coffman CJ, Trogdon JG, Wang V. Trends in dialysis industry consolidation after medicare payment reform, 2006–2016. JAMA Health Forum. 2021;2(11):e213626. doi:10.1001/jamahealthforum.2021.3626
   PubMedGoogle Scholar
• Silva Junior GBD, Oliveira JGR, Oliveira MRB, Vieira LJES, Dias ER. Global costs attributed to chronic kidney disease: a systematic review. Rev Assoc Med Bras. 2018;64(12):1108–1116. doi:10.1590/1806-9282.64.12.1108
   PubMed Web of Science ®Google Scholar
• Elshahat S, Cockwell P, Maxwell AP, Griffin M, O’Brien T, O’Neill C. The impact of chronic kidney disease on developed countries from a health economics perspective: a systematic scoping review. PLoS One. 2020;15(3):e0230512. doi:10.1371/journal.pone.0230512
   PubMed Web of Science ®Google Scholar
• Yeung E, Bello AK, Levin A, et al. Current status of health systems financing and oversight for end-stage kidney disease care: a cross-sectional global survey. BMJ Open. 2021;11(7):e047245. doi:10.1136/bmjopen-2020-047245
   PubMed Web of Science ®Google Scholar
• Alcalde PR, Kirsztajn GM. Expenses of the Brazilian Public Healthcare System with chronic kidney disease. J Bras Nefrol. 2018;40(2):122–129. doi:10.1590/2175-8239-JBN-3918
   PubMedGoogle Scholar
• Brazil, Ministry of Health. National Registry of Health Establishments (Cadastro Nacional de Estabelecimentos de Saúde [CNES]). Available from: http://tabnet.datasus.gov.br/cgi/deftohtm.exe?cnes/cnv/servc2br.def. Accessed April 15, 2023.
   Google Scholar
• Brazil, Ministry of Health. Ordinance number 1112, June, 13, 2002. Determines that the group’s procedures - renal replacement therapy - TRS are financed by the strategic actions and compensation fund - FAEC/Strategic actions. Available from: https://bvsms.saude.gov.br/bvs/saudelegis/gm/2002/prt1112_13_06_2002.html. Accessed June 30, 2023.
   Google Scholar
• Fulton BD. Health care market concentration trends in the United States: evidence and policy responses. Health Aff. 2017;36(9):1530–1538. doi:10.1377/hlthaff.2017.0556
   Web of Science ®Google Scholar
• Pescuma-Junior A, Alves DFA, Mendes A, Bousquat A. International capital companies and the Brazilian health system: a study on renal replacement therapy. Cien Saude Colet. 2021;26(9):4163–4172. doi:10.1590/1413-81232021269.20742020
   PubMed Web of Science ®Google Scholar
• Tsai TC, Jha AK. Hospital consolidation, competition, and quality: is bigger necessarily better? JAMA. 2014;312(1):29–30. doi:10.1001/jama.2014.4692
   PubMed Web of Science ®Google Scholar
• Saeed MK, Ho V, Erickson KF. Consolidation in dialysis Markets-Causes, consequences, and the role of policy. Semin Dial. 2020;33(1):90–99. doi:10.1111/sdi.12855
   PubMed Web of Science ®Google Scholar
• Levin DI, Lingam T, Janiga NJ. 2020 outlook: dialysis clinics and ESRD. Available from: https://healthcareappraisers.com/wp-content/uploads/2020/03/FMVantagePoint_2020-OUTLOOK-DIALYSIS-CLINICS-AND-ESRD.pdf. Accessed April 15, 2023.
   Google Scholar
• Adler JT, Xiang L, Weissman JS, et al. Association of public reporting of medicare dialysis facility quality ratings with access to kidney transplantation. JAMA Network Open. 2021;4(9):e2126719. doi:10.1001/jamanetworkopen.2021.26719
   PubMed Web of Science ®Google Scholar
• Eliason PJ, Heebsh B, McDevitt RC, Roberts JW. How acquisitions affect firm behavior and performance: evidence from the dialysis industry. Q J Econ. 2020;135(1):221–267. doi:10.1093/qje/qjz034
   Web of Science ®Google Scholar
• Erickson KF, Zhao B, Niu J, et al. Association of hospitalization and mortality among patients initiating dialysis with hemodialysis facility ownership and acquisitions. JAMA Network Open. 2019;2(5):e193987. doi:10.1001/jamanetworkopen.2019.3987
   PubMed Web of Science ®Google Scholar
• Whittemore R, Knafl K. The integrative review: updated methodology. J Adv Nurs. 2005;52(5):546–553. doi:10.1111/j.1365-2648.2005.03621.x
   PubMed Web of Science ®Google Scholar
• Pan American Health Organization, World Health Organization. Health sciences descriptors. Available from: https://decs.bvsalud.org/. Accessed November 20, 2022.
   Google Scholar
• Petticrew M, Shekelle P, Stewart LA, Group P. Preferred reporting items for systematic review and explanation. BMJ. 2015;7647:1–25. doi:10.1136/bmj.g7647
   Google Scholar
• Amaral S, McCulloch CE, Lin F, et al. Association between dialysis facility ownership and access to the waiting list and transplant in pediatric patients with end-stage kidney disease in the US. JAMA. 2022;328(5):451–459. doi:10.1001/jama.2022.11231
   PubMed Web of Science ®Google Scholar
• Liu SY, Cheng CY, Wu MY, et al. Effect of profit status in facilities on the mortality of patients on long-term haemodialysis: a nationwide cohort study. BMJ Open. 2021;11(9):e045832. doi:10.1136/bmjopen-2020-045832
   PubMed Web of Science ®Google Scholar
• Dickman S, Mirza R, Kandi M, et al. Mortality at for-profit versus not-for-profit hemodialysis centers: a systematic review and meta-analysis. Int J Health Serv. 2021;51(3):371–378. doi:10.1177/0020731420980682
   PubMed Web of Science ®Google Scholar
• Gander JC, Zhang X, Ross K, et al. Association between dialysis facility ownership and access to kidney transplantation. JAMA. 2019;322(10):957–973. doi:10.1001/jama.2019.12803
   PubMed Web of Science ®Google Scholar
• Erickson KF, Zheng Y, Winkelmayer WC, Ho V, Bhattacharya J, Chertow GM. Consolidation in the dialysis industry, patient choice, and local market competition. Clin J Am Soc Nephrol. 2017;12(3):536–545. doi:10.2215/CJN.06340616
   PubMed Web of Science ®Google Scholar
• Wilson NE. For-profit status and industry evolution in health care markets: evidence from the dialysis industry. Int J Health Econ Manag. 2016;16(4):297–319. doi:10.1007/s10754-016-9192-6
   PubMed Web of Science ®Google Scholar
• Ştefan G, Podgoreanu E, Mircescu G. Hemodialysis system privatization and patient survival: a report from a large registry Eastern Europe cohort. Ren Fail. 2015;37(9):1481–1485. doi:10.3109/0886022X.2015.1077320
   PubMed Web of Science ®Google Scholar
• Brunelli SM, Wilson S, Krishnan M, Nissenson AR. Confounders of mortality and hospitalization rate calculations for profit and nonprofit dialysis facilities: analytic augmentation. BMC Nephrol. 2014;15:121. doi:10.1186/1471-2369-15-121
   PubMed Web of Science ®Google Scholar
• Zhang Y, Thamer M, Kshirsagar O, Cotter DJ, Schlesinger MJ. Dialysis chains and placement on the waiting list for a cadaveric kidney transplant. Transplantation. 2014;98(5):543–551. doi:10.1097/TP.0000000000000106
   PubMed Web of Science ®Google Scholar
• Dalrymple LS, Johansen KL, Romano PS, et al. Comparison of hospitalization rates among for-profit and nonprofit dialysis facilities. Clin J Am Soc Nephrol. 2014;9(1):73–81. doi:10.2215/CJN.04200413
   PubMed Web of Science ®Google Scholar
• Ishida JH, McCulloch CE, Dudley RA, Grimes BA, Johansen KL. Dialysis facility profit status and compliance with a black box warning. JAMA Intern Med. 2013;173(12):1152–1153. doi:10.1001/jamainternmed.2013.979
   PubMed Web of Science ®Google Scholar
• Zhang Y, Thamer M, Kshirsagar O, Cotter DJ. Organizational status of dialysis facilities and patient outcome: does higher injectable medication use mediate increased mortality? Health Serv Res. 2013;48(3):949–971. doi:10.1111/1475-6773.12019
   PubMed Web of Science ®Google Scholar
• Balhara KS, Kucirka LM, Jaar BG, Segev DL. Disparities in provision of transplant education by profit status of the dialysis center. Am J Transplant. 2012;12(11):3104–3110. doi:10.1111/j.1600-6143.2012.04207.x
   PubMed Web of Science ®Google Scholar
• Hynes DM, Stroupe KT, Fischer MJ, et al. Comparing VA and private sector healthcare costs for end-stage renal disease. Med Care. 2012;50(2):161–170. doi:10.1097/MLR.0b013e31822dcf15
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cotter DJ, Thamer M. The effect of dialysis chains on mortality among patients receiving hemodialysis. Health Serv Res. 2011;46(3):747–767. doi:10.1111/j.1475-6773.2010.01219.x
   PubMed Web of Science ®Google Scholar
• Hirth RA, Turenne MN, Wheeler JR, Ma Y, Messana JM. Do resource utilization and clinical measures still vary across dialysis chains after controlling for the local practices of facilities and physicians? Med Care. 2010;48(8):726–732. doi:10.1097/MLR.0b013e3181e3570a
   PubMed Web of Science ®Google Scholar
• Lee DK, Chertow GM, Zenios SA. Reexploring differences among for-profit and nonprofit dialysis providers. Health Serv Res. 2010;45(3):633–646. doi:10.1111/j.1475-6773.2010.01103.x
   PubMed Web of Science ®Google Scholar
• Pozniak AS, Hirth RA, Banaszak-Holl J, Wheeler JR. Predictors of chain acquisition among independent dialysis facilities. Health Serv Res. 2010;45(2):476–496. doi:10.1111/j.1475-6773.2010.01081.x
   PubMed Web of Science ®Google Scholar
• Van Wyck D, Robertson J, Nissenson A, Provenzano R, Kogod D. Relationship among length of facility ownership, clinical performance, and mortality. Clin J Am Soc Nephrol. 2010;5(2):248–251. doi:10.2215/CJN.03700609
   PubMed Web of Science ®Google Scholar
• Mehrotra R, Khawar O, Duong U, et al. Ownership patterns of dialysis units and peritoneal dialysis in the United States: utilization and outcomes. Am J Kidney Dis. 2009;54(2):289–298. doi:10.1053/j.ajkd.2009.01.262
   PubMed Web of Science ®Google Scholar
• Foley RN, Fan Q, Liu J, et al. Comparative mortality of hemodialysis patients at for-profit and not-for-profit dialysis facilities in the United States, 1998 to 2003: a retrospective analysis. BMC Nephrol. 2008;9:6. doi:10.1186/1471-2369-9-6
   PubMed Web of Science ®Google Scholar
• Thamer M, Zhang Y, Kaufman J, Cotter D, Dong F, Hernán MA. Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis. JAMA. 2007;297(15):1667–1674. doi:10.1001/jama.297.15.1667
   PubMed Web of Science ®Google Scholar
• Gitto L, Santoro D, Sobbrio G. Choice of dialysis treatment and type of medical unit (private vs public): application of a recursive bivariate probit. Health Econ. 2006;15(11):1251–1256. doi:10.1002/hec.1139
   PubMed Web of Science ®Google Scholar
• Thamer M, Zhang Y, Kaufman J, Stefanik K, Cotter DJ. Factors influencing route of administration for epoetin treatment among hemodialysis patients in the United States. Am J Kidney Dis. 2006;48(1):77–87. doi:10.1053/j.ajkd.2006.03.040
   PubMed Web of Science ®Google Scholar
• Szczech LA, Klassen PS, Chua B, et al. Associations between CMS’s Clinical Performance Measures project benchmarks, profit structure, and mortality in dialysis units. Kidney Int. 2006;69(11):2094–2100. doi:10.1038/sj.ki.5000267
   PubMed Web of Science ®Google Scholar
• Devereaux PJ, Schünemann HJ, Ravindran N, et al. Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: a systematic review and meta-analysis. JAMA. 2002;288(19):2449–2457. doi:10.1001/jama.288.19.2449
   PubMed Web of Science ®Google Scholar
• Ozgen H, Ozcan YA. A national study of efficiency for dialysis centers: an examination of market competition and facility characteristics for production of multiple dialysis outputs. Health Serv Res. 2002;37(3):711–732. doi:10.1111/1475-6773.00045
   PubMed Web of Science ®Google Scholar
• Irvin RA. Quality of care differences by ownership in United States renal dialysis facilities. ASAIO J. 2000;46(6):775–778. doi:10.1097/00002480-200011000-00023
   PubMed Web of Science ®Google Scholar
• Garg PP, Frick KD, Diener-West M, Powe NR. Effect of the ownership of dialysis facilities on patients’ survival and referral for transplantation. N Engl J Med. 1999;341(22):1653–1660. doi:10.1056/NEJM199911253412205
   PubMed Web of Science ®Google Scholar
• Furth SL, Hwang W, Neu AM, Fivush BA, Powe NR. For-profit versus not-for-profit dialysis care for children with end stage renal disease. Pediatrics. 1999;104(3 Pt 1):519–524. doi:10.1542/peds.104.3.519
   PubMed Web of Science ®Google Scholar
• Griffiths RI, Powe NR, Gaskin DJ, Anderson GF, de Lissovoy GV, Whelton PK. The production of dialysis by for-profit versus not-for-profit freestanding renal dialysis facilities. Health Serv Res. 1994;29(4):473–487.
   PubMed Web of Science ®Google Scholar
• de Lissovoy G, Powe NR, Griffiths RI, et al. The relationship of provider organizational status and erythropoietin dosing in end stage renal disease patients. Med Care. 1994;32(2):130–140. doi:10.1097/00005650-199402000-00004
   PubMed Web of Science ®Google Scholar
• Salman B, Hussain M, Shafique K, Imtiaz S, Dhrolia MF. Risk factors of hospitalization among chronic kidney disease patients in tertiary care hospitals - A single-center experience. Saudi J Kidney Dis Transpl. 2018;29(5):1150–1158. doi:10.4103/1319-2442.243973
   PubMedGoogle Scholar
• Mathew AT, Rosen L, Pekmezaris R, et al. Potentially avoidable readmissions in United States hemodialysis patients. Kidney Int Rep. 2017;3(2):343–355. doi:10.1016/j.ekir.2017.10.014
   PubMed Web of Science ®Google Scholar
• Bao C, Bardhan I. Antecedents of patient health outcomes in dialysis clinics: a national study. J Cent Cathedra. 2017;10(1):25–48. doi:10.1108/JCC-09-2016-0015
   Google Scholar
• Kimmel PL, Varela MP, Peterson RA, et al. Interdialytic weight gain and survival in hemodialysis patients: effects of duration of ESRD and diabetes mellitus. Kidney Int. 2000;57(3):1141–1151. doi:10.1046/j.1523-1755.2000.00941.x
   PubMed Web of Science ®Google Scholar
• Held PJ, Levin NW, Bovbjerg RR, Pauly MV, Diamond LH. Mortality and duration of hemodialysis treatment. JAMA. 1991;265:871–875.
   PubMed Web of Science ®Google Scholar
• Goldman DP, Vaiana M, Romley JA. The emerging importance of patient amenities in hospital care. N Engl J Med. 2010;363(23):2185–2187. doi:10.1056/NEJMp1009501
   PubMed Web of Science ®Google Scholar
• Hirth RA, Chernew ME, Orzol SM. Ownership, competition, and the adoption of new technologies and cost-saving practices in a fixed-price environment. Inquiry. 2000;37(3):282–294.
   PubMed Web of Science ®Google Scholar
• Lin W-H, Lin C-T, Chang H-F, et al. Financial performance of non-profit hospitals in Taiwan. J Inf Optim Sci. 2011;32:419–431.
   Google Scholar
• Brazil, Ministry of Health. National data from the Unified Health System (DATASUS). Health Information. Outpatient and hospital production. Available from: https://datasus.saude.gov.br/informacoes-de-saude-tabnet/. Accessed May 20, 2023.
   Google Scholar
• Neves PDMM, Sesso RCC, Thomé FS, Lugon JR, Nasicmento MM. Brazilian Dialysis Census: analysis of data from the 2009-2018 decade. Braz J Bras Nefrol. 2020;42(2):191–200. doi:10.1590/2175-8239-JBN-2019-0234
   PubMed Web of Science ®Google Scholar
• Fontenelle LF, Camargo MBJ, Bertoldi AD, Gonçalves H, Maciel ELN, Barros AJD. Coverage by health insurance or discount cards: a household survey in the coverage area of the Family Health Strategy. Cad Saude Publica. 2017;33(10):e00141515. doi:10.1590/0102-311X00141515
   PubMed Web of Science ®Google Scholar
• Novais M, Martins CB. Profile of Plan and SUS Beneficiaries and Access to Health Services – PNAD 2003 and 2008. Brasil: Instituo de Estudos da Saúde Suplementar; 2010. Available from: www.iess.org.br/sites/default/files/2021-04/TD35.pdf. Accessed December 20, 2023.
   Google Scholar
• Nelson KM, Chapko MK, Reiber G, Boyko EJ. The association between health insurance coverage and diabetes care; data from the 2000 Behavioral Risk Factor Surveillance System. Health Serv Res. 2005;40(2):361–372. doi:10.1111/j.1475-6773.2005.00361.x
   PubMed Web of Science ®Google Scholar
• Freeman HE, Corey CR. Insurance status and access to health services among poor persons. Health Serv Res. 1993;28(5):531–541.
   PubMed Web of Science ®Google Scholar
• Barra ABL, Silva APRD, Canziani MEF, Lugon JR, Matos JPS. Survival in hemodialysis in Brazil according to the source of payment for the treatment: Public Healthcare System (SUS) versus private insurance. J Bras Nefrol. 2023;45(3):302–309. doi:10.1590/2175-8239-JBN-2022-0131en
   PubMedGoogle Scholar
• da Rocha EP, Kojima CA, Modelli de Andrade LG, et al. Comparing survival outcomes between hemodialysis and hemodiafiltration using real-world data from Brazil. J Clin Med. 2024;13(2):594. doi:10.3390/jcm13020594
   PubMed Web of Science ®Google Scholar
• Mohottige D, Gibson K. Staying on track to achieve racial justice in kidney care. Nat Rev Nephrol. 2022;18(2):72–73. doi:10.1038/s41581-021-00520-5
   PubMed Web of Science ®Google Scholar
• Kevin Tucker J. Social Justice as a Tool to Eliminate Inequities in Kidney Disease. Semin Nephrol. 2021;41(3):203–210. doi:10.1016/j.semnephrol.2021.05.001
   PubMed Web of Science ®Google Scholar
• Farah SS, Alhaji MM, Ahmed D, et al. Barriers to Kidney Transplantation as a Choice of Renal Replacement Therapy. Transplant Proc. 2018;50(10):3165–3171. doi:10.1016/j.transproceed.2018.07.005
   PubMed Web of Science ®Google Scholar
• Zee J, Zhao J, Subramanian L, et al. Perceptions about the dialysis modality decision process among peritoneal dialysis and in-center hemodialysis patients. BMC Nephrol. 2018;19(1):298. doi:10.1186/s12882-018-1096-x
   PubMedGoogle Scholar
• Glickman A, Lin E, Berns JS. Conflicts of interest in dialysis: a barrier to policy reforms. Semin Dial. 2020;33(1):83–89. doi:10.1111/sdi.12848
   PubMed Web of Science ®Google Scholar
• Streja E, Park J, Chan TY, et al. Erythropoietin dose and mortality in hemodialysis patients: marginal structural model to examine causality. Int J Nephrol. 2016;2016:6087134. doi:10.1155/2016/6087134
   PubMedGoogle Scholar
• Thamer M, Zhang Y, Kaufman J, Kshirsagar O, Cotter D, Hernán MA. Major declines in epoetin dosing after prospective payment system based on dialysis facility organizational status. Am J Nephrol. 2014;40(6):554–560. doi:10.1159/000370334
   PubMed Web of Science ®Google Scholar
• Hirth RA Y, Turenne MN, Wheeler JR, et al. The initial impact of Medicare’s new prospective payment system for kidney dialysis. Am J Kidney Dis. 2013;62(4):662–669. doi:10.1053/j.ajkd.2013.03.044
   PubMed Web of Science ®Google Scholar
• Okpechi IG, Jha V, Cho Y, et al. The case for increased peritoneal dialysis utilization in low- and lower-middle-income countries. Nephrology. 2022;27(5):391–403. doi:10.1111/nep.14024
   PubMed Web of Science ®Google Scholar
• van de Luijtgaarden MW, Jager KJ, Stel VS, et al. Global differences in dialysis modality mix: the role of patient characteristics, macroeconomics and renal service indicators. Nephrol Dial Transplant. 2013;28(5):1264–1275.
   PubMed Web of Science ®Google Scholar
• Mercado-Martinez FJ, Silva DGV, Souza SS, Zillmer JGV, Lopes SGR, Böell JE. Living with renal insufficiency: obstacles to hemodialysis treatment from the perspective of sick people and their families. Physis. 2015;25(1). doi:10.1590/S0103-73312015000100005
   Google Scholar
• Pancras G, Shayo J, Anaeli A. Non-medical facilitators and barriers towards accessing haemodialysis services: an exploration of ethical challenges. BMC Nephrol. 2018;19(1):342. doi:10.1186/s12882-018-1140-x
   PubMedGoogle Scholar
• Mercado-Martínez FJ, Correa-Mauricio ME. Viviendo con hemodiálisis y sin seguridad social: las voces de los enfermos renales y sus familias [Living in hemodialysis without social insurance: the voices of renal sick people and their families]. Salud Publica Mex. 2015;57(2):155–160. Spanish.
   PubMedGoogle Scholar
• McDonald SP, Ullah S, Dansie K, et al. The burden of travel-time and distance traveled for hemodialysis patients in Australian Major City Areas. Kidney Int Rep. 2023;8(5):1105–1108. doi:10.1016/j.ekir.2023.02.1077
   PubMed Web of Science ®Google Scholar
• Msy N, Charu V, Johnson DW, O’Shaughnessy MM, Mallett AJ. National and international kidney failure registries: characteristics, commonalities, and contrasts. Kidney Int. 2022;101(1):23–35. doi:10.1016/j.kint.2021.09.024
   PubMed Web of Science ®Google Scholar
• United States Renal Data System. USRDS Annual Data Report: epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Available from: https://www.niddk.nih.gov/about-niddk/strategic-plans-reports/usrds. Accessed June 30, 2023.
   Google Scholar
• Almasri J, Alsawas M, Mainou M, et al. Outcomes of vascular access for hemodialysis: a systematic review and meta-analysis. J Vasc Surg. 2016;64(1):236–243. doi:10.1016/j.jvs.2016.01.053
   PubMed Web of Science ®Google Scholar
• Franco RP, Chula DC, de Moraes TP, Campos RP. Health insurance provider and endovascular treatment availability are associated with different hemodialysis vascular access profiles: a Brazilian national survey. Front Nephrol. 2022;2:985449. doi:10.3389/fneph.2022.985449
   PubMedGoogle Scholar
• Brazil, Ministry of Health. Ordinance number 1675, June 7, 2018. Criteria for the organization, operation and financing of care for people with Chronic Kidney Disease in the Unified Health System. Available from: https://bvsms.saude.gov.br/bvs/saudelegis/gm/2018/prt1675_08_06_2018.html. Accessed May 24, 2023.
   Google Scholar
• Thomé FS, Sesso R, Lopes AA, Lugon JR, Martins CT. Brazilian chronic dialysis survey 2017. J Bras Nefrol. 2019;41(2):208–214. doi:10.1590/2175-8239-JBN-2018-0178
   PubMedGoogle Scholar
• Emrani Z, Amiresmaili M, Daroudi R, Najafi MT, Akbari Sari A. Payment systems for dialysis and their effects: a scoping review. BMC Health Serv Res. 2023;23(1):45. doi:10.1186/s12913-022-08974-4
   PubMed Web of Science ®Google Scholar
• Santos NRD. 30 years of SUS: the beginning, the pathway and the target. Cien Saude Colet. 2018;23(6):1729–1736. doi:10.1590/1413-81232018236.06092018
   PubMed Web of Science ®Google Scholar
• Noronha JC, Noronha GS, Pereira TR, Costa AM. The future of the Brazilian Health System: a short review of its pathways towards an uncertain and discouraging horizon. Cien Saude Colet. 2018;23(6):2051–2059. doi:10.1590/1413-81232018236.05732018
   PubMed Web of Science ®Google Scholar
• Vieira SF. Health financing in Brazil and the goals of the 2030 Agenda: high risk of failure. Rev Saude Publica. 2020;54:127. doi:10.11606/s1518-8787.2020054002414
   PubMed Web of Science ®Google Scholar